Chilton Investment CO Inc. Novartis Ag Transaction History
Chilton Investment CO Inc.
- $3.48 Billion
- Q1 2024
A detailed history of Chilton Investment CO Inc. transactions in Novartis Ag stock. As of the latest transaction made, Chilton Investment CO Inc. holds 2,300 shares of NVS stock, worth $248,699. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,300
Previous 2,300
-0.0%
Holding current value
$248,699
Previous $232,000
4.31%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,349Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.34 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.34 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$785 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$651 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$640 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $233B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...